×

Methods of treatment using IL-31RA

  • US 9,139,651 B2
  • Filed: 01/07/2011
  • Issued: 09/22/2015
  • Est. Priority Date: 02/14/2005
  • Status: Active Grant
First Claim
Patent Images

1. A method of treating a patient with prurigo nodularis, comprising administering a therapeutically effective amount of a soluble IL-31RA homodimeric receptor to the patient, wherein the soluble IL-31RA homodimeric receptor comprises amino acid residues 20-519 of SEQ ID NO:

  • 6 fused to the Fc region of an immunoglobulin.

View all claims
  • 0 Assignments
Timeline View
Assignment View
    ×
    ×